Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-29 FMR LLC Conversion +304,576 1,118,054
2018-01-29 FMR LLC Conversion · Series B Preferred Stock −2,194,357 0
2018-01-29 FMR LLC Conversion · Series C Preferred Stock −821,596 0
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion +2,584 1,418,005
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion +66 36,358
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion +849,794 2,267,799
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion +21,789 58,147
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion +127,269 2,395,068
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion +3,263 61,410
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion · Series A Preferred Stock −6,971 0
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion · Series A Preferred Stock −179 0
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion · Series B Preferred Stock −2,292,320 0
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion · Series B Preferred Stock −58,777 0
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion · Series C Preferred Stock −343,310 0
2018-01-29 Presidio Partners 2007 GP, L.P. 10% owner Conversion · Series C Preferred Stock −21,789 0
2018-01-29 venBio Global Strategic Fund II L.P. 10% owner Conversion +1,196,552 1,461,552
2018-01-29 venBio Global Strategic Fund II L.P. 10% owner Conversion · Series C Preferred Stock −3,227,700 0
2018-01-29 Remeditex Ventures LLC 10% owner Conversion +2,650 1,585,504
2018-01-29 Remeditex Ventures LLC 10% owner Conversion +871,583 2,457,087
2018-01-29 Remeditex Ventures LLC 10% owner Conversion +304,576 2,761,663

Page 20 of 22 · 425 trades